Cantabio Pharmaceuticals
PrivateLast Round
Grant
Feb 6, 2024
Total Funding Raised
$600,000
Company Overview
Cantabio Pharmaceuticals is a biotechnology company that develops novel disease-modifying therapeutics and diagnostics for neurodegenerative and metabolic conditions such as Parkinson's and Alzheimer's disease.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Drug Discovery
Business Model
B2B
Customer Profile
Services & Consulting
AI Layer
Application
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Cantabio Pharmaceuticals Comparables
Compare Cantabio Pharmaceuticals with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Origami Therapeutics | 87% | |
| Amathus Therapeutics | 85% | |
| Retromer Therapeutics | 82% | |
Cantabio Pharmaceuticals Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Grant | Feb 6, 2024 | ||||
| Grant | Aug 17, 2023 | ||||
| Grant | Sep 2, 2020 | ||||
| Convertible Debt | Feb 2, 2017 | ||||
| Private Placement | Oct 21, 2015 |
Cantabio Pharmaceuticals Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| The Michael J. Fox Foundation for Parkinson's Research | Grant |
| Yorkville Advisors | Convertible Debt |
Market signals
Structured signals derived from secondary market and firmographic data.
- Apr 24, 2026
Monthly visitors increased 48% MoM, reaching 2.1K.
- Jan 25, 2026
Monthly visitors grew 64% MoM, reaching 1.2K.
Cantabio Pharmaceuticals Filings
SEC and related filings with document metadata.
| Typed | Date | Amount Offered | Amount Sold | Filling | Pages | Download |
|---|---|---|---|---|---|---|
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Frequently Asked Questions
Common questions about Cantabio Pharmaceuticals's valuation, stock price, and market status.